EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones

Yi Hua, Mingxia Song, Qiaoyue Guo, Yiqin Luo, Xianqing Deng, Yushan Huang

Molecules · 2023

DOI: 10.3390/molecules28083408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Yi Hua und 5 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Center, Jinggangshan University, Ji'an 343009, China. Hauptthemen laut MEDLINE: Histamine H3 Antagonists, Receptors, Histamine H3. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

H3R is becoming an attractive and promising target for epilepsy treatment as well as the discovery of antiepileptics. In this work, a series of 6-aminoalkoxy-3,4-dihydroquinolin-2(1H)-ones was prepared to screen their H3R antagonistic activities and antiseizure effects. The majority of the target compounds displayed a potent H3R antagonistic activity. Among them, compounds 2a, 2c, 2h, and 4a showed submicromolar H3R antagonistic activity with an IC50 of 0.52, 0.47, 0.12, and 0.37 μM, respectively. The maximal electroshock seizure (MES) model screened out three compounds (2h, 4a, and 4b) with antiseizure activity. Meanwhile, the pentylenetetrazole (PTZ)-induced seizure test gave a result that no compound can resist the seizures induced by PTZ. Additionally, the anti-MES action of compound 4a fully vanished when it was administrated combined with an H3R agonist (RAMH). These results showed that the antiseizure role of compound 4a might be achieved by antagonizing the H3R receptor. The molecular docking of 2h, 4a, and PIT with the H3R protein predicted their possible binding patterns and gave a presentation that 2h, 4a, and PIT had a similar binding model with H3R.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histamine H3 AntagonistsReceptors, Histamine H3RatsAnimalsHumansHistamineRats, WistarMolecular Docking SimulationDose-Response Relationship, DrugAnticonvulsantsSeizuresPentylenetetrazole

Stichwörter der Autor:innen

3,4-dihydroquinolin-2(1H)-oneH3R antagonistsanticonvulsantantiepilepticsantiseizure

Substanzen

HistamineHistamine H3 AntagonistsReceptors, Histamine H3AnticonvulsantsPentylenetetrazole

Autor:innen und Institutionen

  • Health Science Center, Jinggangshan University, Ji'an 343009, China.
  • Center for Evidence Based Medical and Clinical Research, First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hua, Y., Song, M., Guo, Q., Luo, Y., Deng, X., & Huang, Y. (2023). Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones. Molecules. https://doi.org/10.3390/molecules28083408

Vancouver

Hua Y, Song M, Guo Q, Luo Y, Deng X, Huang Y. Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones. Molecules. 2023. doi:10.3390/molecules28083408

BibTeX
@article{Hua2023,
  author = {Hua, Yi and Song, Mingxia and Guo, Qiaoyue and Luo, Yiqin and Deng, Xianqing and Huang, Yushan},
  title = {Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28083408}
}
Kostenlos starten →